Back
Speaker illustration

undefined undefined undefined

Presentations

The impact on CD146 congestion biomarker by early adding SGLT2i dapaglifozin to intravenous loop diuretic in patients with acute heart failure

Event: Heart Failure 2025

Topic: Pharmacotherapy

Session: Congestion, SGLT2 inhibitors and novel therapies

Access
Like
Thumbnail

Management of acute and residual congestion in patients with acute heart failure by adding dapaglifozin to intravenous loop diuretic therapy-ENDORSE-HF

Event: Heart Failure 2024

Topic: Clinical

Session: New tools to detect and treat acute heart failure

Access
Like
Thumbnail

Association between left ventricular global longitudinal strain and the severity of clinical parameters in patients with acute heart failure

Event: Heart Failure 2022

Topic: Epidemiology, Prognosis, Outcome

Session: Heart Failure ePosters - focus on Acute Heart Failure

Access
Like
Thumbnail

The prevalence and prognosis of multi-organ injury among patients with acute heart failure

Event: Heart Failure 2021

Topic: Epidemiology, Prognosis, Outcome

Session: ePoster session

Access
Like
Thumbnail

Lung injury, a clinical issue among patients with acute heart failure?

Event: Heart Failure 2019

Topic: Epidemiology, Prognosis, Outcome

Session: Acute Heart Failure – Epidemiology, Prognosis, Outcome

Access
Like
Thumbnail

Heart failure with mid-range ejection fraction: characteristics and outcome in patients with and without acute kidney injury

Event: Heart Failure 2018

Topic: Heart Failure with Mid-Range Ejection Fraction (HFmrEF)

Session: Chronic Heart Failure – Pathophysiology and Mechanisms

Access
Like
Thumbnail

ESC 365 is supported by

novartis Explore sponsored resources